Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/01/2873225/0/en/Tevogen-Bio-Announces-Full-Year-2023-Financial-Results-and-Upcoming-Operational-Objectives.html
https://www.globenewswire.com/news-release/2024/04/26/2870556/0/en/Tevogen-Bio-CEO-Highlights-Expected-Reporting-of-a-94-9-Million-Liability-Elimination-AI-Initiative-and-Leadership-Appointments.html
https://www.globenewswire.com/news-release/2024/04/11/2861471/0/en/Tevogen-Bio-s-Chief-Scientific-Officer-Speaks-on-the-Harnessing-of-Cytotoxic-T-Lymphocytes-CTLs-to-Target-Cancers.html
https://www.globenewswire.com/news-release/2024/04/03/2856914/0/en/Tevogen-Bio-Appoints-Tapan-V-Shah-as-Head-of-Investor-Relations-and-Corporate-Development.html
https://www.globenewswire.com/news-release/2024/03/28/2853967/0/en/Tevogen-Bio-Reports-Series-A-1-Preferred-Stock-Investment-at-10-Conversion-Price.html
https://www.globenewswire.com/news-release/2024/03/27/2853265/0/en/Tevogen-Bio-Announces-Series-A-1-Preferred-Stock-Investment.html